Skip to main content

Table 1 Summary of assessments

From: Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial

Assessment

Type

Method of completion

Timeline

Screening

Baseline

6 months

16 months

Care home eligibility

CRF

Researcher assessment

X

   

Training review

CRF

Researcher assessment

X

   

Dementia awareness training

CRF

Dementia awareness trainer

X

   

Resident screening (demographics)

CRF

Researcher assessment

X

   

Staff mapper screening

CRF

Researcher assessment

X

   

Consent (staff mapper, resident (includes personal/nominated consultee), staff proxy informant, RF proxy informant)

Consent Form

Self-completion (witnessed)

X

  

X

Participant eligibility (staff mapper, resident, staff proxy informant, RF proxy informant)

CRF

Researcher assessment

X

  

X

Participant contact details (resident, staff proxy informant, RF proxy informant)

CRF

Researcher assessment

X

  

X

Cohen-Mansfield Agitation Index (CMAI) abridged

Questionnaire booklet

Independent researcher observations (R)

 

X

X

X

Pittsburgh Agitation Scale (PAS)

Questionnaire booklet

Independent researcher observations (R)

 

X

X

X

Care home manager demographics

Questionnaire booklet

Researcher interview (CM)

 

X

X

X

Care home demographics

Questionnaire booklet

Researcher interview (CM)

 

X

X

X

Group Living Home Characteristics (GLHC)

Questionnaire booklet

Researcher assessment (CH)

 

X

X

X

Environmental Audit Tool (EAT)

Questionnaire booklet

Researcher observations (CH)

 

X

X

X

Quality of Interactions Schedule (QUIS)

Questionnaire booklet

Researcher observations (R/S)

 

X

X

X

Staff proxy informant demographics

Questionnaire booklet

Researcher interview (SP)

 

X

X

X

Resident demographics

Questionnaire booklet

Researcher assessment

 

X

X

X

RF proxy informant demographics

Questionnaire booklet

Researcher interview (RF)

 

X

X

X

Cohen-Mansfield Agitation Index (CMAI)

Questionnaire booklet

Researcher interview (SP)

 

X

X

X

Neuropsychiatric Inventory (NPI-NH)

Questionnaire booklet

Researcher interview (SP)

 

X

X

X

Functional Assessment Staging (FAST)

Questionnaire booklet

Researcher interview (SP)

 

X

X

X

Clinical Dementia Rating (CDR)

Questionnaire booklet

Researcher interview (SP)

 

X

X

X

DEMQOL-Proxy

Questionnaire booklet

Researcher interview (SP/RF)

 

X

X

Xa

EQ-5D-5 L

Questionnaire booklet

Researcher interview (SP/RF/R)

 

X

X

Xa

QUALID

Questionnaire booklet

Researcher interview (SP/RF)

 

X

X

Xa

QOL-AD

Questionnaire booklet

Researcher interview (R)

 

X

X

X

Resident comorbidities

Questionnaire booklet

Researcher assessment

 

X

X

X

Health care resource use

Questionnaire booklet

Researcher assessment

 

X

X

X

Prescription medications

CRF

Researcher assessment

 

X

X

X

Resident registration

Questionnaire booklet

Researcher assessment

 

X

 

X

Staff booklet

Questionnaire booklet

Self-completed (S)

 

X

X

X

General Health Questionnaire (GHQ-12)

Questionnaire booklet

Self-completed (S)

 

X

X

 

Sense of Competence in Dementia care Staff (SCIDS) scale

Questionnaire booklet

Self-completed (S)

 

X

X

X

Safety reporting

CRF

Researcher assessment

 

Monthly following randomisation

RUSAE Report

CRF

Researcher assessment

 

As highlighted.

   

Mapper training

Cycle 1

Cycle 2

Cycle 3

Mapper training

CRF

DCM™ trainer

X

   

DCM™ adherence

Questionnaire booklet/CRF

DCM™ expert/ independent reviewer

 

X

X

X

DCM™ briefing summary

CRF

CH mapper

 

X

X

X

DCM™ feedback summary

CRF

CH mapper

 

X

X

X

  1. Key: CRF Case Report Form, CH care home observations, CM care home manager, DEMQOL-Proxy Dementia Quality of Life measure – proxy version, EQ-5D-5 L EuroQol five dimensions, five levels, QUALID Quality of Life in Late-Stage Dementia, QOL-AD Quality of Life in Alzheimer’s disease measure, R resident, RF relative/friend proxy informant, RUSAE Related Unexpected Serious Adverse Event, S staff, SP staff proxy informant, Xa – only for relative/friend informants consented at baseline and still meeting eligibility criteria